by EmpathiCSubstanceS | Apr 21, 2022 | Alcoholism, Iboga, Kambo, LSD, MDMA Sassafras Molly, Microdosing, Neuropathy, NN-Dimethyltryptamine, OCD, Parkinson's Disease, Psilocybin Magic Mushroom
Follow-up data from a Phase III trial is the latest to suggest that MDMA—also known as ecstasy—could improve mental health when combined with therapy. The study found that MDMA-assisted therapy was better than talk therapy alone in relieving the symptoms of patients...
by EmpathiCSubstanceS | Apr 20, 2022 | Cannabis Marijuana, DMT, Iboga, Kambo, LSD, MDMA Sassafras Molly, Microdosing, Neuropathy, NN-Dimethyltryptamine, OCD, Pain
The world of microdosing is a lot bigger than just LSD or mushrooms. Researchers and users explain dosages, effects, and risks. There’s no scientific definition of microdosing, but generally, it means taking 1/20th to 1/10th the usual dose of a drug. LSD and mushrooms...
by EmpathiCSubstanceS | Apr 20, 2022 | Cancer, Iboga, Kambo, LSD, Parkinson's Disease, Psilocybin Magic Mushroom, Psychotropics, PTSD
Adults who have at some time in their life used psilocybin – a psychedelic substance produced by some types of mushrooms – are 30% less likely to have opioid use disorder, according to a nationally representative survey of US adults reported in the journal Scientific...
by EmpathiCSubstanceS | Apr 20, 2022 | Ayahuasca, Cancer, CBC, Iboga, Pain, Psilocybin Magic Mushroom, San Pedro Mescaline
Psilocybin, the psychedelic compound found in magic mushrooms, helps to “open up” depressed people’s brains, even after use, enabling brain regions to talk more freely to one another. These are the findings of a new analysis of brain scans from close to 60 people...
by EmpathiCSubstanceS | Feb 2, 2022 | Cannabis Marijuana, Iboga, Kambo, LSD, Microdosing, Neuropathy, NN-Dimethyltryptamine, Pain, Parkinson's Disease, Psilocybin Magic Mushroom, Psychotropics, PTSD, San Pedro Mescaline
This question can be approached from a number of different levels. At the lowest functionally relevant level, how do the hallucinogenic compounds themselves interact with a certain neurotransmitter receptor to alter neuronal activity? Then at the neuronal population...
by EmpathiCSubstanceS | Jan 13, 2022 | Chronic Pain, Cluster Headaches, Iboga, Kambo, Pain, Psilocybin Magic Mushroom, San Pedro Mescaline
Perhaps one of the most important psychedelic science articles published in 2021 came when psychopharmacologist Suresh Muthukumaraswamy and colleagues Anna Forsythe and Thomas Lumley called out the big elephant in the room of psychedelic clinical trials. The...
